Musculoskeletal treatment affects bones, muscles, ligaments, tendons and nerves. Beginning Jan. 1, Humana will use Cohere’s technology to grant authorizations from initial diagnosis to treatment plan selection, or across the entire episode of care, for musculoskeletal conditions.
About 2 million members and 3,500-plus physicians will have access to the process.
The new musculoskeletal prior authorization process will be deployed in Alabama, Georgia, Indiana, Kentucky, Michigan, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and West Virginia.
More articles on payers:
CommonSpirit, BCBS of Texas split to affect thousands
What Anthem, Cigna, UnitedHealth’s hospital-based imaging policies entail
US News: Best Medicare Advantage plans for 2021
